Epigenetic reprogramming safely modifies multiple genes in T cells simultaneously for CAR-T therapies
Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic editing platform that enables safe modification of multiple genes in primary human T cells, addressing a key manufacturing and sca…